Company Info
Year Established1995
Ticker
TAK
Exchange
NYSE
Contacts
Christophe WeberPresident & CEO
Costa Saroukos
CFO
Yoshihiro Nakagawa
Global General Counsel
Andrew S. Plump, M.D., Ph.D.
President, R&D
Company Description
Dyax, a Takeda company, is biotechnology company that seeks to develop drugs using its patented phage display technology.
